Effectively managing malignancy in patients with Inflammatory Bowel Disease (IBD) requires a comprehensive and proactive approach. The latest guidance from the American Gastroenterological Association (AGA) offers valuable strategies for healthcare providers. What are the essential practices recommended to address malignancy in IBD, and how can they improve patient outcomes?
Author: Abhay Panchal
Zimmer Biomet is making significant strides in the Ambulatory Surgery Center (ASC) market, reflecting the broader industry trend towards outpatient care. This strategic shift aims to enhance patient outcomes and reduce healthcare costs. Becker’s spoke with Nnamdi Njoku, president of sports medicine, surgery, upper extremities, and restorative therapies at Zimmer Biomet, to see what else the company intends to accomplish through its latest partnership. What innovative approaches is Zimmer Biomet implementing, and how will they shape the future of ASCs?
Dr. Lisa Mathew, a partner with South Denver Gastroenterology, is challenging the notion that private practice is routine or dull. She emphasizes that working in private practice offers a dynamic professional experience, encompassing practice management innovation and enhanced patient care delivery.Dr. Mathew highlights the flexibility and innovation within the GI community, allowing for the trial of new technologies and optimizing patient access to care.
Dr. Brent Neuschwander-Tetri discusses the latest AASLD guidance on diagnosing and treating Metabolic Associated Steatotic Liver Disease (MASLD). This new guidance provides comprehensive recommendations aimed at improving patient outcomes and advancing our understanding of MASLD. What are the key strategies outlined in this guidance, and how can they transform current clinical practices?
In a compelling interview, Dr. Eran Segal, a renowned microbiome expert, delves into the intriguing connection between the microbiome and obesity. Dr. Segal shares his insights on how gut bacteria can influence weight gain and metabolic health, shedding light on potential new approaches to managing obesity. What groundbreaking discoveries has his research unveiled, and how might these findings revolutionize our understanding of weight management?
Harish Gagneja, MD, FASGE, (CMO at Austin Gastroenterology and a member of the GI Alliance Physician Executive Board) emphasizes the importance of healthcare providers prioritizing their own health and wellness to deliver the best patient care. By focusing on self-care, medical professionals can enhance their well-being, reduce burnout, and improve patient outcomes. What strategies are recommended to achieve this balance, and how can they impact the quality of care?
Leading AI Edge solutions designer AAEON has teamed up with Insign Medical Technology Inc. to create ‘EndoDASS’, an AI-assisted colonoscopy system. This innovative solution employs AI to help gastroenterologists identify potentially malignant lesions, thereby enhancing the precision and safety of colonoscopy procedures.EndoDASS utilizes convolutional neural networks (CNNs), 3D imaging, and data augmentation to provide a clear view of the colon. Powered by AAEON’s BOXER-8641AI Fanless Embedded AI System with NVIDIA® Jetson AGX Orin™, the system offers real-time image analysis with up to 200 TOPS of advanced inferencing performance.
The AI Scholars Program, hosted by the AI for GI organization, is designed to empower the next generation of gastroenterologists with cutting-edge artificial intelligence (AI) skills. This innovative program provides comprehensive training and mentorship, bridging the gap between technology and medical expertise. What unique opportunities does this program offer, and how is it shaping the future of gastroenterology?
In the past five years, United Digestive has made 20 significant moves that have shaped its path towards innovation and growth. From strategic acquisitions to groundbreaking partnerships, the organization has consistently pushed the boundaries of gastroenterology. What are these transformative moves, and how have they positioned United Digestive as a leader in the field?
A recent article on Medscape explores the potential of circulating tumor DNA (ctDNA) to guide clinical decisions in gastrointestinal cancers. Here are three key insights from the discussion: